Desmoplastic small round cell tumor (DSRCT) is a rare soft tissue tumor of
primitive origin occurring primarily in children and young adults. Based on
published reports in the literature, the response to conventional chemothe
rapy is poor. We report three pediatric patients successfully treated with
dose-intensive, multimodal therapy. Between August 1994 and March 1998, we
evaluated three consecutive patients with DSRCT at Children's Hospital and
Regional Medical Center, Seattle, Washington. We established the diagnosis
based on clinical presentation, radiologic staging, and pathologic review w
ith immunohistochemical staining. All patients received a combined modality
protocol including dose-intensive chemotherapy (two of them with periphera
l blood stem cell [PBSC] support), second look surgery, and consolidative l
ocal irradiation. The patients remain in continuous remission at 66, 42, an
d 26 months after diagnosis, respectively. Two of our patients were younger
than any previously reported patient, extending the age group for which DS
RCT should be considered on diagnosis of small round cell tumors. The unifo
rm survival achieved in our series indicates potential benefit for the comb
ination of dose-intensive multiagent chemotherapy, local irradiation, and a
ggressive surgical approach in this disease.